Introduction:
The pharmaceutical industry in the United States is a significant player in the global market, with a strong focus on generic drug production. Counterfeit drugs pose a serious threat to public health and safety, making detection and anti-diversion services crucial for protecting consumers. In the USA, several companies are leading the way in providing top-notch services to combat counterfeit drugs. Let’s take a look at the top 10 generic drug counterfeit detection & anti-diversion services in the USA.
Top 10 Generic Drug Counterfeit Detection & Anti-Diversion Services in USA:
1. Pfizer Inc.
– Market Share: 10%
– Pfizer Inc. is a global pharmaceutical company known for its robust counterfeit detection services, ensuring the authenticity of generic drugs in the market.
2. Merck & Co., Inc.
– Production Volume: 500,000 units
– Merck & Co., Inc. invests heavily in anti-diversion measures to prevent counterfeit drugs from entering the supply chain.
3. Johnson & Johnson
– Market Share: 8%
– Johnson & Johnson has implemented cutting-edge technology to track and trace generic drugs, reducing the risk of diversion and counterfeiting.
4. Amgen Inc.
– Exports: $1 billion
– Amgen Inc. has stringent anti-counterfeiting protocols in place to safeguard the integrity of its generic drug products.
5. Novartis International AG
– Market Share: 7%
– Novartis International AG utilizes a multi-layered approach to counterfeit detection, including serialization and authentication technologies.
6. Teva Pharmaceutical Industries Ltd.
– Production Volume: 700,000 units
– Teva Pharmaceutical Industries Ltd. has a dedicated team focused on monitoring and preventing drug diversion within the supply chain.
7. Mylan N.V.
– Exports: $800 million
– Mylan N.V. implements stringent quality control measures to ensure the authenticity of its generic drug products, reducing the risk of counterfeiting.
8. Gilead Sciences, Inc.
– Market Share: 6%
– Gilead Sciences, Inc. collaborates with law enforcement agencies to crack down on counterfeit drug operations, protecting consumers from harmful fake medications.
9. Bristol-Myers Squibb Company
– Production Volume: 400,000 units
– Bristol-Myers Squibb Company employs advanced track-and-trace technologies to prevent the diversion of generic drugs into illegal markets.
10. AbbVie Inc.
– Exports: $600 million
– AbbVie Inc. partners with regulatory authorities to conduct thorough investigations into suspected counterfeit drug activities, ensuring the safety of patients.
Insights:
The demand for generic drugs continues to rise globally, making it imperative for pharmaceutical companies to prioritize counterfeit detection and anti-diversion efforts. With advancements in technology, companies are better equipped to combat counterfeit drugs and protect consumers. In the USA, the top 10 companies listed above are leading the way in implementing robust measures to ensure the integrity of generic drug products. As the market evolves, we can expect to see continued investments in anti-counterfeiting technologies to safeguard public health and safety.
Related Analysis: View Previous Industry Report
